Search - tctmd.com

Displaying 281 - 300 of 352

Sort: Relevancy | Date

News Industry News

Significant Patient Benefits With Edwards SAPIEN Valve Demonstrated In 5-Year PARTNER Trial Data

September 13, 2014

News Daily News

MitraClip Repair Safe, Effective for MR in Large European Registry

September 02, 2014

News Conference News ESC 2014

Another Strike Against Thrombectomy in 1-Year TASTE Results

Todd Neale

September 02, 2014

News Industry News

Medtronic Viva® Cardiac Resynchronization Therapy-Pacemaker Now Available in U.S.

August 25, 2014

News Daily News

Mesh-Covered Stent Safe in STEMI Patients but Risk of TLR, TVR Higher vs BMS

July 08, 2014

News Daily News

Greater Early LV Mass Regression After TAVR Reduces Rehospitalization

June 27, 2014

News Industry News

Study Shows CRT-D Devices with Medtronic AdaptivCRT(TM) Associated with Reduction of Costs of Atrial Fibrillation

June 18, 2014

News Daily News

PROSPECT Substudy: Persistently High CRP Predicts Future MACE in ACS Patients After PCI

June 04, 2014

News Conference News EuroPCR 2014

Early Data Show Novel Catheter-Implanted Device Benefits Patients with Left Heart Failure

Caitlin E. Cox

May 22, 2014

News Daily News

REMINDER Study: Eplerenone Safe, Effective in STEMI Patients Without Heart Failure

May 05, 2014

News Industry News

Medtronic Viva® Cardiac Resynchronization Therapy-Pacemaker Now Available in Europe

May 01, 2014

News Daily News

Diabetes Drug Aleglitazar Fails to Reduce Ischemic Outcomes in Diabetics with Recent ACS

L.A. McKeown

April 11, 2014

News Daily News

Patients with Severe Pulmonary Hypertension Benefit from TAVR Despite Increased Mortality

L.A. McKeown

March 13, 2014

News Daily News

Most Nonculprit Lesions with Plaque Rupture Do not Lead to Increased Events

March 13, 2014

News Daily News

COPD Common in TAVR Patients, Associated with Increased CV Mortality

Jason Kahn

March 06, 2014

News Daily News

Bleeding Common but Often Unreported in ACS Patients on Antiplatelet Therapy

L.A. McKeown

February 06, 2014

News Conference News Cell Therapy 2014

Repeat Cell Therapy for Chronic Heart Failure Being Tested in Randomized Trials

January 26, 2014

News Daily News

TAVR-Linked Conduction Abnormality Worsens Functional Status, but Not Mortality

Jason Kahn

January 16, 2014

News Industry News

Abbott's MitraClip® Treatment Demonstrates Positive Results for Patients with Degenerative Mitral Regurgitation at Prohibitive Risk for Surgery

October 30, 2013

News Daily News

INFUSE-AMI: Thirty-Day Reduction in Infarct Size May Translate to 1-Year Benefit

Caitlin E. Cox

October 11, 2013

Advertisement

Significant Patient Benefits With Edwards SAPIEN Valve Demonstrated In 5-Year PARTNER Trial Data

MitraClip Repair Safe, Effective for MR in Large European Registry

Another Strike Against Thrombectomy in 1-Year TASTE Results

Medtronic Viva® Cardiac Resynchronization Therapy-Pacemaker Now Available in U.S.

Mesh-Covered Stent Safe in STEMI Patients but Risk of TLR, TVR Higher vs BMS

Greater Early LV Mass Regression After TAVR Reduces Rehospitalization

Study Shows CRT-D Devices with Medtronic AdaptivCRT(TM) Associated with Reduction of Costs of Atrial Fibrillation

PROSPECT Substudy: Persistently High CRP Predicts Future MACE in ACS Patients After PCI

Early Data Show Novel Catheter-Implanted Device Benefits Patients with Left Heart Failure

REMINDER Study: Eplerenone Safe, Effective in STEMI Patients Without Heart Failure

Medtronic Viva® Cardiac Resynchronization Therapy-Pacemaker Now Available in Europe

Diabetes Drug Aleglitazar Fails to Reduce Ischemic Outcomes in Diabetics with Recent ACS

Patients with Severe Pulmonary Hypertension Benefit from TAVR Despite Increased Mortality

Most Nonculprit Lesions with Plaque Rupture Do not Lead to Increased Events

COPD Common in TAVR Patients, Associated with Increased CV Mortality

Bleeding Common but Often Unreported in ACS Patients on Antiplatelet Therapy

Repeat Cell Therapy for Chronic Heart Failure Being Tested in Randomized Trials

TAVR-Linked Conduction Abnormality Worsens Functional Status, but Not Mortality

Abbott's MitraClip® Treatment Demonstrates Positive Results for Patients with Degenerative Mitral Regurgitation at Prohibitive Risk for Surgery

INFUSE-AMI: Thirty-Day Reduction in Infarct Size May Translate to 1-Year Benefit

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content